UBS Group AG - GALERA THERAPEUTICS INC ownership

GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 38 filers reported holding GALERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of GALERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$26,108
+74.1%
8,368
+35.0%
0.00%
Q1 2022$15,000
-46.4%
6,200
+2.0%
0.00%
Q4 2021$28,000
+833.3%
6,078
+2040.1%
0.00%
Q2 2021$3,000
-92.1%
284
-93.5%
0.00%
Q1 2021$38,000
+90.0%
4,349
+122.3%
0.00%
Q4 2020$20,000
+185.7%
1,956
+146.3%
0.00%
Q3 2020$7,000
-66.7%
794
-72.7%
0.00%
Q2 2020$21,000
+110.0%
2,904
+189.0%
0.00%
Q1 2020$10,000
-77.8%
1,005
-70.3%
0.00%
Q4 2019$45,0003,3890.00%
Other shareholders
GALERA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 613,223$2,815,0000.83%
Sofinnova Investments, Inc. 3,083,712$14,154,0000.83%
Novo Holdings A/S 2,459,021$11,287,0000.53%
ACUTA CAPITAL PARTNERS, LLC 262,500$1,205,0000.51%
Tekla Capital Management LLC 898,374$4,124,0000.13%
Aristides Capital LLC 20,000$92,0000.04%
XTX Topco Ltd 13,499$62,0000.04%
Taylor Wealth Management Partners 11,635$53,0000.02%
Blackstone Inc. 1,678,984$7,707,0000.02%
Belvedere Trading LLC 96,486$255,0000.01%
View complete list of GALERA THERAPEUTICS INC shareholders